(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of DYNLL1 mRNA] CTD PMID:31150632 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression ISO RGD:731011 6480464 o, p'-DDT results in increased expression of DYNLL1 mRNA CTD PMID:24096037 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression EXP 6480464 o, p'-DDT results in increased expression of DYNLL1 mRNA CTD PMID:24096037 17alpha-ethynylestradiol multiple interactions ISO RGD:731011 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DYNLL1 mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression ISO RGD:731011 6480464 Ethinyl Estradiol results in increased expression of DYNLL1 mRNA CTD PMID:14976129 more ... 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of DYNLL1 mRNA CTD PMID:17108234 more ... 17beta-estradiol increases expression ISO RGD:731010 6480464 Estradiol results in increased expression of DYNLL1 mRNA CTD PMID:12154049 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:731011 6480464 Dihydrotestosterone results in increased expression of DYNLL1 mRNA CTD PMID:17023530 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:731010 6480464 2 more ... CTD PMID:31675489 2,3',4,4',5-Pentachlorobiphenyl increases expression ISO RGD:731011 6480464 2 more ... CTD PMID:31388691 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:731011 6480464 [Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of DYNLL1 mRNA, [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DYNLL1 mRNA CTD PMID:16214954 , PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of DYNLL1 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:731011 6480464 Tetrachlorodibenzodioxin results in increased expression of DYNLL1 mRNA CTD PMID:15328365 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:731011 6480464 Tetrachlorodibenzodioxin affects the expression of DYNLL1 mRNA CTD PMID:18343893 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of DYNLL1 mRNA CTD PMID:22298810 , PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of DYNLL1 mRNA CTD PMID:16960034 2,3,7,8-Tetrachlorodibenzofuran affects expression ISO RGD:731011 6480464 2 more ... CTD PMID:18343893 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of DYNLL1 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of DYNLL1 mRNA CTD PMID:21346803 2-amino-14,16-dimethyloctadecan-3-ol decreases expression ISO RGD:731010 6480464 2-amino-14, 16-dimethyloctadecan-3-ol results in decreased expression of DYNLL1 protein CTD PMID:32044396 2-methylcholine affects expression ISO RGD:731010 6480464 beta-methylcholine affects the expression of DYNLL1 mRNA CTD PMID:21179406 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:731010 6480464 tetrabromobisphenol A results in decreased expression of DYNLL1 protein CTD PMID:31675489 3-[3-acetyl-4-[3-(tert-butylamino)-2-hydroxypropoxy]phenyl]-1,1-diethylurea decreases expression ISO RGD:731011 6480464 Celiprolol results in decreased expression of DYNLL1 mRNA CTD PMID:15262839 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of DYNLL1 mRNA CTD PMID:36041667 4,4'-sulfonyldiphenol increases expression ISO RGD:731010 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of DYNLL1 protein CTD PMID:34186270 4-amino-2,6-dinitrotoluene affects expression EXP 6480464 4-amino-2, 6-dinitrotoluene affects the expression of DYNLL1 mRNA CTD PMID:21346803 4-hydroxyphenyl retinamide increases expression ISO RGD:731011 6480464 Fenretinide results in increased expression of DYNLL1 mRNA CTD PMID:28973697 4-tert-Octylphenol decreases expression EXP 6480464 4-tert-octylphenol results in decreased expression of DYNLL1 mRNA CTD PMID:17011747 4-tert-Octylphenol increases expression EXP 6480464 4-tert-octylphenol results in increased expression of DYNLL1 mRNA CTD PMID:17011747 5-aza-2'-deoxycytidine increases expression ISO RGD:731010 6480464 Decitabine results in increased expression of DYNLL1 mRNA CTD PMID:19151715 acetamide increases expression EXP 6480464 acetamide results in increased expression of DYNLL1 mRNA CTD PMID:31881176 aconitine decreases expression EXP 6480464 Aconitine results in decreased expression of DYNLL1 protein CTD PMID:33236894 acrylamide increases expression ISO RGD:731010 6480464 Acrylamide results in increased expression of DYNLL1 mRNA CTD PMID:32763439 afimoxifene increases expression ISO RGD:731010 6480464 afimoxifene results in increased expression of DYNLL1 mRNA CTD PMID:12154049 aflatoxin B1 increases methylation ISO RGD:731010 6480464 Aflatoxin B1 results in increased methylation of DYNLL1 gene CTD PMID:27153756 all-trans-retinoic acid increases expression ISO RGD:731010 6480464 Tretinoin results in increased expression of DYNLL1 mRNA CTD PMID:17045167 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of DYNLL1 mRNA CTD PMID:16483693 aristolochic acid A increases expression ISO RGD:731010 6480464 aristolochic acid I results in increased expression of DYNLL1 mRNA CTD PMID:33212167 arsenite(3-) multiple interactions ISO RGD:731010 6480464 arsenite promotes the reaction [G3BP1 protein binds to DYNLL1 mRNA] CTD PMID:32406909 atrazine decreases expression ISO RGD:731010 6480464 Atrazine results in decreased expression of DYNLL1 mRNA CTD PMID:22378314 azoxystrobin increases expression ISO RGD:731010 6480464 azoxystrobin results in increased expression of DYNLL1 mRNA CTD PMID:33512557 benidipine affects expression ISO RGD:731011 6480464 benidipine affects the expression of DYNLL1 mRNA CTD PMID:15721868 benzo[a]pyrene decreases methylation ISO RGD:731010 6480464 Benzo(a)pyrene results in decreased methylation of DYNLL1 5' UTR, Benzo(a)pyrene results in decreased methylation of DYNLL1 promoter CTD PMID:27901495 benzo[a]pyrene diol epoxide I increases expression ISO RGD:731010 6480464 7 more ... CTD PMID:19150397 bis(2-ethylhexyl) phthalate increases expression ISO RGD:731011 6480464 Diethylhexyl Phthalate results in increased expression of DYNLL1 mRNA CTD PMID:19850644 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:731011 6480464 PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of DYNLL1 mRNA] CTD PMID:19850644 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of DYNLL1 mRNA CTD PMID:24066056 , PMID:25181051 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of DYNLL1 mRNA CTD PMID:36041667 bisphenol A decreases expression ISO RGD:731010 6480464 bisphenol A results in decreased expression of DYNLL1 protein CTD PMID:31675489 bisphenol A increases methylation ISO RGD:731010 6480464 bisphenol A results in increased methylation of DYNLL1 gene CTD PMID:31601247 bisphenol A affects expression ISO RGD:731010 6480464 bisphenol A affects the expression of DYNLL1 mRNA CTD PMID:30903817 bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of DYNLL1 mRNA CTD PMID:36041667 buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of DYNLL1 mRNA CTD PMID:24136188 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of DYNLL1 mRNA CTD PMID:33453195 CGP 52608 multiple interactions ISO RGD:731010 6480464 CGP 52608 promotes the reaction [RORA protein binds to DYNLL1 gene] CTD PMID:28238834 chloropicrin decreases expression ISO RGD:731010 6480464 chloropicrin results in decreased expression of DYNLL1 mRNA CTD PMID:26352163 chloropicrin increases expression ISO RGD:731010 6480464 chloropicrin results in increased expression of DYNLL1 mRNA CTD PMID:26352163 choline multiple interactions ISO RGD:731011 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of DYNLL1 mRNA CTD PMID:20938992 chromium(6+) affects expression ISO RGD:731011 6480464 chromium hexavalent ion affects the expression of DYNLL1 mRNA CTD PMID:28472532 ciguatoxin CTX1B affects expression ISO RGD:731011 6480464 Ciguatoxins affects the expression of DYNLL1 mRNA CTD PMID:18353800 clofibric acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of DYNLL1 mRNA CTD PMID:17602206 cocaine affects expression EXP 6480464 Cocaine affects the expression of DYNLL1 mRNA CTD PMID:20187946 copper(II) sulfate decreases expression ISO RGD:731010 6480464 Copper Sulfate results in decreased expression of DYNLL1 mRNA CTD PMID:19549813 crocidolite asbestos decreases expression ISO RGD:731011 6480464 Asbestos, Crocidolite results in decreased expression of DYNLL1 mRNA CTD PMID:29279043 curcumin increases expression ISO RGD:731010 6480464 Curcumin results in increased expression of DYNLL1 mRNA CTD PMID:17198877 cyclosporin A decreases expression ISO RGD:731010 6480464 Cyclosporine results in decreased expression of DYNLL1 mRNA CTD PMID:25562108 decabromodiphenyl ether decreases expression ISO RGD:731010 6480464 decabromobiphenyl ether results in decreased expression of DYNLL1 protein CTD PMID:31675489 dexamethasone decreases expression ISO RGD:731011 6480464 Dexamethasone results in decreased expression of DYNLL1 mRNA CTD PMID:22733784 diethylstilbestrol decreases expression EXP 6480464 Diethylstilbestrol results in decreased expression of DYNLL1 mRNA CTD PMID:17011747 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of DYNLL1 mRNA CTD PMID:17011747 diuron decreases expression EXP 6480464 Diuron results in decreased expression of DYNLL1 mRNA CTD PMID:21551480 enzyme inhibitor multiple interactions ISO RGD:731010 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of DYNLL1 protein CTD PMID:23301498 ethanol increases expression ISO RGD:731011 6480464 Ethanol results in increased expression of DYNLL1 mRNA CTD PMID:30319688 ethanol multiple interactions ISO RGD:731011 6480464 Ethanol affects the expression of and affects the splicing of DYNLL1 mRNA CTD PMID:30319688 finasteride increases expression EXP 6480464 Finasteride results in increased expression of DYNLL1 mRNA CTD PMID:24136188 flutamide increases expression EXP 6480464 Flutamide results in increased expression of DYNLL1 mRNA CTD PMID:24136188 folic acid multiple interactions ISO RGD:731011 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of DYNLL1 mRNA CTD PMID:20938992 fulvestrant increases expression ISO RGD:731010 6480464 fulvestrant results in increased expression of DYNLL1 mRNA CTD PMID:12154049 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of DYNLL1 mRNA CTD PMID:22061828 glafenine increases expression EXP 6480464 Glafenine results in increased expression of DYNLL1 mRNA CTD PMID:24136188 hydralazine multiple interactions ISO RGD:731010 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of DYNLL1 mRNA CTD PMID:17183730 hydrogen peroxide decreases expression ISO RGD:731010 6480464 Hydrogen Peroxide results in decreased expression of DYNLL1 mRNA CTD PMID:12419474 Indeno[1,2,3-cd]pyrene decreases expression ISO RGD:731011 6480464 indeno(1 more ... CTD PMID:26377693 ivermectin decreases expression ISO RGD:731010 6480464 Ivermectin results in decreased expression of DYNLL1 protein CTD PMID:32959892 L-methionine multiple interactions ISO RGD:731011 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of DYNLL1 mRNA CTD PMID:20938992 lead(0) affects expression ISO RGD:731010 6480464 Lead affects the expression of DYNLL1 mRNA CTD PMID:28903495 lead(2+) affects expression ISO RGD:731010 6480464 Lead affects the expression of DYNLL1 mRNA CTD PMID:28903495 leflunomide decreases expression ISO RGD:731010 6480464 leflunomide results in decreased expression of DYNLL1 mRNA CTD PMID:28988120 , PMID:29427785 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of DYNLL1 mRNA CTD PMID:30467583 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of DYNLL1 mRNA CTD PMID:17602206 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of DYNLL1 mRNA CTD PMID:19041683 N-nitrosodiethylamine increases expression ISO RGD:731011 6480464 Diethylnitrosamine results in increased expression of DYNLL1 mRNA CTD PMID:24535843 ozone decreases expression EXP 6480464 Ozone results in decreased expression of DYNLL1 mRNA CTD PMID:26667333 , PMID:28623178 p-tert-Amylphenol increases expression EXP 6480464 4-tert-octylphenol results in increased expression of DYNLL1 mRNA CTD PMID:17011747 p-tert-Amylphenol decreases expression EXP 6480464 4-tert-octylphenol results in decreased expression of DYNLL1 mRNA CTD PMID:17011747 p-toluidine decreases expression EXP 6480464 4-toluidine results in decreased expression of DYNLL1 mRNA CTD PMID:27638505 paracetamol affects expression ISO RGD:731011 6480464 Acetaminophen affects the expression of DYNLL1 mRNA CTD PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of DYNLL1 mRNA CTD PMID:33387578 paraquat decreases expression ISO RGD:731011 6480464 Paraquat results in decreased expression of DYNLL1 mRNA CTD PMID:12595580 paraquat increases expression EXP 6480464 Paraquat results in increased expression of DYNLL1 mRNA CTD PMID:20388547 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of DYNLL1 mRNA CTD PMID:16328009 phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of DYNLL1 mRNA CTD PMID:19162173 phenobarbital affects expression ISO RGD:731011 6480464 Phenobarbital affects the expression of DYNLL1 mRNA CTD PMID:23091169 phenobarbital multiple interactions ISO RGD:731011 6480464 NR1I3 protein affects the reaction [Phenobarbital results in increased expression of DYNLL1 mRNA] CTD PMID:19482888 phenobarbital increases expression ISO RGD:731011 6480464 Phenobarbital results in increased expression of DYNLL1 mRNA CTD PMID:19482888 piperonyl butoxide increases expression EXP 6480464 Piperonyl Butoxide results in increased expression of DYNLL1 mRNA CTD PMID:22484513 pirinixic acid decreases expression ISO RGD:731011 6480464 pirinixic acid results in decreased expression of DYNLL1 mRNA CTD PMID:17426115 , PMID:18445702 pirinixic acid increases expression ISO RGD:731011 6480464 pirinixic acid results in increased expression of DYNLL1 mRNA CTD PMID:18301758 , PMID:23811191 propiconazole increases expression ISO RGD:731011 6480464 propiconazole results in increased expression of DYNLL1 mRNA CTD PMID:21278054 quercetin decreases expression ISO RGD:731010 6480464 Quercetin results in decreased expression of DYNLL1 mRNA CTD PMID:21632981 raloxifene increases expression ISO RGD:731010 6480464 Raloxifene Hydrochloride results in increased expression of DYNLL1 mRNA CTD PMID:12154049 resveratrol increases expression ISO RGD:731010 6480464 resveratrol results in increased expression of DYNLL1 mRNA CTD PMID:12154049 resveratrol multiple interactions ISO RGD:731010 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of DYNLL1 mRNA CTD PMID:23557933 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of DYNLL1 mRNA CTD PMID:28374803 rotenone increases expression ISO RGD:731010 6480464 Rotenone results in increased expression of DYNLL1 mRNA CTD PMID:33512557 sarin decreases expression ISO RGD:731010 6480464 Sarin results in decreased expression of DYNLL1 mRNA CTD PMID:19522546 sarin increases expression ISO RGD:731010 6480464 Sarin results in increased expression of DYNLL1 mRNA CTD PMID:19522546 sevoflurane affects expression EXP 6480464 sevoflurane affects the expression of DYNLL1 mRNA CTD PMID:15967596 silver atom decreases expression ISO RGD:731011 6480464 Silver results in decreased expression of DYNLL1 mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:731011 6480464 Silver results in decreased expression of DYNLL1 mRNA CTD PMID:27131904 sulindac decreases expression EXP 6480464 Sulindac results in decreased expression of DYNLL1 mRNA CTD PMID:24136188 sulindac sulfide decreases expression ISO RGD:731010 6480464 sulindac sulfide results in decreased expression of DYNLL1 mRNA CTD PMID:12734198 T-2 toxin increases expression ISO RGD:731010 6480464 T-2 Toxin results in increased expression of DYNLL1 mRNA CTD PMID:34581912 tamoxifen affects expression ISO RGD:731011 6480464 Tamoxifen affects the expression of DYNLL1 mRNA CTD PMID:17555576 tamoxifen increases expression EXP 6480464 Tamoxifen results in increased expression of DYNLL1 mRNA CTD PMID:19400957 tamoxifen increases expression ISO RGD:731011 6480464 Tamoxifen results in increased expression of DYNLL1 mRNA CTD PMID:19400957 tert-butyl hydroperoxide decreases expression ISO RGD:731010 6480464 tert-Butylhydroperoxide results in decreased expression of DYNLL1 mRNA CTD PMID:12419474 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of DYNLL1 mRNA] CTD PMID:31150632 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of DYNLL1 mRNA CTD PMID:31150632 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of DYNLL1 mRNA CTD PMID:34492290 tolcapone decreases expression EXP 6480464 tolcapone results in decreased expression of DYNLL1 mRNA CTD PMID:24136188 trichloroethene increases expression ISO RGD:731011 6480464 Trichloroethylene results in increased expression of DYNLL1 mRNA CTD PMID:19448997 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of DYNLL1 mRNA CTD PMID:33387578 trichloroethene increases methylation EXP 6480464 Trichloroethylene results in increased methylation of DYNLL1 gene CTD PMID:27618143 Triptolide increases expression ISO RGD:731011 6480464 triptolide results in increased expression of DYNLL1 mRNA CTD PMID:32835833 troglitazone increases expression ISO RGD:731011 6480464 troglitazone results in increased expression of DYNLL1 mRNA CTD PMID:28973697 valdecoxib increases expression EXP 6480464 valdecoxib results in increased expression of DYNLL1 mRNA CTD PMID:24136188 valproic acid increases methylation ISO RGD:731010 6480464 Valproic Acid results in increased methylation of DYNLL1 gene CTD PMID:29154799 valproic acid increases expression ISO RGD:731010 6480464 Valproic Acid results in increased expression of DYNLL1 mRNA CTD PMID:23179753 valproic acid multiple interactions ISO RGD:731010 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of DYNLL1 mRNA CTD PMID:17183730 valproic acid affects expression ISO RGD:731011 6480464 Valproic Acid affects the expression of DYNLL1 mRNA CTD PMID:17292431 vancomycin decreases expression ISO RGD:731011 6480464 Vancomycin results in decreased expression of DYNLL1 mRNA CTD PMID:18930951